Samil Pharmaceutical Co. Ltd. (000520) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Samil Pharmaceutical Co. Ltd. (000520:KRX), powered by AI.

Current Price
₩8,890
P/E Ratio
-28.4
Market Cap
192.8B
Sector
Healthcare
What is the Samil Pharmaceutical Co. Ltd. stock price forecast?

Samil Pharmaceutical Co. Ltd. is currently trading at ₩8,890. View real-time AI analysis on Alpha Lenz.

What is Samil Pharmaceutical Co. Ltd. insider trading activity?

View the latest insider trading data for Samil Pharmaceutical Co. Ltd. on Alpha Lenz.

What is Samil Pharmaceutical Co. Ltd.'s P/E ratio?

Samil Pharmaceutical Co. Ltd.'s P/E ratio is -28.4.

Samil Pharmaceutical Co. Ltd.

KRX · 000520
₩8,890
Ask about Samil Pharmaceutical Co. Ltd.'s future dividend policy...
Alpha Chat Insight

Samil Pharmaceutical Co. Ltd. trades at a P/E of -28.4 (undervalued) with modest ROE of -3.7%. 3Y revenue CAGR of 17.8% highlights clear growth momentum.

Ask for details

Company Overview

Samil Pharmaceutical Co. Ltd. is a key player in the pharmaceutical industry, primarily focusing on the research, development, and distribution of a diverse range of medical products. The company's portfolio spans prescription medications, over-the-counter drugs, and various pharmaceutical solutions that serve multiple therapeutic areas. Samil Pharmaceutical is committed to advancing healthcare by leveraging innovation to create effective and safe medicinal products. Operating within a highly regulated sector, the company addresses critical healthcare needs and partners with both domestic and international healthcare providers to ensure accessibility and effectiveness of treatments. Samil's role in the market is significant, contributing to advancements in therapeutic solutions and improving patient outcomes. As part of the broader pharmaceutical ecosystem, the company collaborates with research institutions and other industry stakeholders to foster advancements in medical science and enhance the overall health of communities globally.

CEO허승범
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees583

Company Statistics

FY 2024

Profile

₩192,840,199,790Market Cap
₩219,699,586,440Revenue
21.69MShares Out
583Employees

Margins

36.83%Gross
3.39%EBITDA
0.05%Operating
-1.64%Pre-Tax
-2.56%Net

Valuation

-28.40P/E
0.91P/B
0.73EV/Sales
40.91EV/EBITDA
-52.90P/FCF

Growth (CAGR)

17.84%Rev 3Yr
12.65%Rev 5Yr
-34.36%Op Inc 3Yr
-52.80%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.47%ROA
-3.70%ROE
0.38%ROIC

Financial Health

₩5,136,995,020Cash & Cash Equivalents
₩213,810,295,860Net Debt
124.31%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Samil Pharmaceutical Co. Ltd. (ticker: 000520) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 583 employees. Market cap is $192.8B.

The current price is ₩8,890 with a P/E ratio of -28.4x and P/B of 0.91x.

ROE is -3.70% and operating margin is 0.05%. Annual revenue is $219.7B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Samil Pharmaceutical Co. Ltd. (Healthcare) Stock Forecast & Analysis ₩8,890 | Alpha Lenz